Macrogenics (MGNX) Cash from Investing Activities Growth (1y) (2013 - 2026)
Macrogenics (MGNX) Cash from Investing Activities Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Macrogenics |
260.14 Mn |
193.63 Mn |
- |
357.67% |
| Date | Value |
|---|
| Mar 31, 2026 |
357.67% |
| Dec 31, 2025 |
-259.14% |
| Sep 30, 2025 |
-157.22% |
| Jun 30, 2025 |
-179.34% |
| Mar 31, 2025 |
-60.06% |
| Dec 31, 2024 |
6.81% |
| Sep 30, 2024 |
206.19% |
| Jun 30, 2024 |
141.80% |
| Mar 31, 2024 |
-11.75% |
| Dec 31, 2023 |
770.73% |
| Sep 30, 2023 |
-146.60% |
| Jun 30, 2023 |
-592.54% |
| Mar 31, 2023 |
252.01% |
| Dec 31, 2022 |
57.29% |
| Sep 30, 2022 |
2,849.18% |
| Jun 30, 2022 |
66.73% |
| Mar 31, 2022 |
46.05% |
| Dec 31, 2021 |
15.69% |
| Sep 30, 2021 |
93.95% |
| Jun 30, 2021 |
-66.30% |
